Security key
03237H101
Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)
CUSIP: 03237H101
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 49,784,011
- Total 13F value
- $188,180,501
- Share change
- +4,807,547
- Put/Call ratio
- 160%
- SEC-reported price per share
- $3.78
- Number of holders
- 120
- Value change
- +$19,458,443
- Number of buys
- 60
- Number of sells
- 58
- Shares outstanding
- 110,465,093
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
120
Top holders
10
AMLX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Amylyx Pharmaceuticals, Inc. SEC filings
Amylyx Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03237H101
Recent filing periods:
Ownership snapshot
Top reported holders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Panacea Innovation Ltd
Disclosed value leader
TCG Crossover Management,...
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
Lead comparable stake: 2.6%
13D/G row: Panacea Innovation Ltd
Showing 1-6 of 15 holder rows.
Quick read
Panacea Innovation Ltd leads the comparable SEC ownership view at 2.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Panacea Innovation Ltd's linked filing trail.
Comparable ownership
Top 5
Panacea Innovation Ltd
2.6%
TCG Crossover Management, LLC
4.2%
VANGUARD GROUP INC
2.8%
BlackRock, Inc.
2.3%
PERCEPTIVE ADVISORS LLC
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Panacea Innovation Ltd |
13D/G
Panacea Venture Healthcare Fund II, L.P.
|
2.6%
|
$11,792,000
2,200,000 shares
|
$0 | 31 Dec 2024 |
| TCG Crossover Management, LLC |
13F
Company
|
4.2%
|
$15,045,951
4,643,812 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
2.8%
|
$10,010,450
3,089,645 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
2.3%
|
$8,256,186
2,548,206 shares
|
— | 30 Sep 2024 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
1.9%
|
$6,887,103
2,125,649 shares
|
— | 30 Sep 2024 |
| Alyeska Investment Group, L.P. |
13F
Company
|
1.8%
|
$6,555,881
2,023,420 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
120
Shares
49,784,011
Rows available
120
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
107
Q4 2024 holders
120
Holder diff
13
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend